Meet our Team

CEO – Pacific Therapy Access & CLH Healthcare Academy
20 Years of Medical Device Commercialization Experience
Professor of US Health Policy at Southern Methodist University

Chris Hanna is the founder and CEO of Pacific Therapy Access and CLH Academy. Pacific Therapy Access is a medical device professional services organization and a proven leader in healthcare policy.

With 20+ years of significant commercial and health policy leadership, Hanna has commercialized multiple Class II and III external and active implantable neurostimulation devices.

Hanna developed the commercial, operational infrastructure, health policy, reimbursement, and prior authorization strategies for Spark Biomedical, an auricular transcutaneous stimulator treating opioid withdrawal.

Prior to Spark Biomedical, Hanna was a company founder and principal commercial leader at Nuvectra Medical, a spinal cord stimulation company, where he effectively built the business’ operational infrastructure, reimbursement, and prior authorization teams.

Before joining Nuvectra, Mr. Hanna was the Director of Health Policy and Reimbursement at St. Jude Neuromodulation, leading a team of 25 case managers that processed over 22,000 prior authorizations annually for spinal cord stimulators. Additionally, he oversaw the Field Reimbursement team that educated 1,000+ customers on proper procedure billing and coding. Hanna successfully led St. Jude’s Congressional lobbying efforts in Washington, DC, in removing the medical device tax from the Affordable Care Act.

Hanna’s expertise and opinions on commercial and health policy are nationally recognized and respected. Hanna is honored to be an Adjunct Professor of US Health Policy at Southern Methodist University, where he earned his MBA. He received his Bachelor of Finance degree from Clemson University.

Director – Pacific Therapy Access
Expert in Medical Device Reimbursement & Policy
20 Years Medical Device Experience
Certified Professional Coder

Kathy O’Neill leads the Health Policy & Reimbursement teams for Pacific Access with over 20 years of experience in the medical device industry. Prior to Pacific Access, Ms. O’Neill was Senior Manager for Healthcare Economics for Angiodynamics, Inc. where she most recently developed the AMA/CPT Coding Submission for a unique, critical care endovascular device. She also created the Reimbursement Strategy and Infrastructure for the Vascular Interventions Division. Before that, Ms. O’Neill was Senior Manager of Reimbursement, Health Policy, and Prior Authorization for Nuvectra Medical, where she worked with leadership and external stakeholders to affect both Government and Commercial Health Policy in the US Neuromodulation Market. Ms. O’Neill also spent 10 years working at Medtronic, Inc. in the Neuromodulation Division, as a Senior Manager of Field Reimbursement for over 40 field sales representatives and regularly interacted with hospital, physicians, and facilities providing reimbursement economics and education. She educated over 100+ physicians and residents/fellows on reimbursement for various neuromodulation therapies. Ms. O’Neill has also spent several years working in wound management, most notably with Smith & Nephew, Inc. and Osiris Therapeutics, Inc., on obtaining Government and Commercial Coverage and appropriate coding and reimbursement for novel biologics considered to be medical devices.

Ms. O’Neill holds an MBA with a focus in Health and Medical Services Administration from Widener University, a Bachelor of Science in Accounting and Health Care Financial Management for LaSalle University and is an AAPC-Certified Outpatient Coder.

Director – Business Development & External Affairs

Kenneth R. Callahan III was the Chief of Staff for Deputy Secretary Hargan in the Immediate Office of the Secretary (IOS) at the US Department of Health and Human Services (HHS). In this role, Callahan was responsible for department-wide strategic initiatives including but not limited to healthcare regulatory reform, innovation, and healthcare finance. He directly supported the HHS Secretary on policy development and execution for the Office of the National Coordinator for Health IT, the Office of the Chief Information Officer, the Office of Administration, and the Office of Finance. Callahan supported the Deputy Secretary on executing the HHS/CMS regulatory agenda, allocation and distribution of $175 billion from the Provider Relief Fund, Digital Health, Congressional affairs, Gubernatorial affairs, Rural Health, Kidney Initiatives, Global Affairs, External affairs, and much more. He played major roles in cross-departmental initiatives such as telehealth expansion, Stark and Anti-kickback reform, the Rural Health Action Plan, Health IT, and launching LymeX – the largest public-private partnership to combat Lyme disease in history. As part of his inter-agency responsibilities, he regularly interfaced with the White House Domestic Policy Council, Council of Economic Advisors, National Security Council, Office of Management and Budget, U.S. Department of Agriculture, and U.S. Department of State on these initiatives.

He began his career on Capitol Hill working for Congressman David Joyce (R-OH). Later, he worked at the National Republican Congressional Committee and then subsequently, the Republican National Committee before joining the Deputy Secretary’s office in January of 2018.

Callahan received his BA from Ohio Wesleyan University where he was an all-conference NCAA lacrosse player and his Masters in Health Administration (MHA) from Cornell University.